Hugo Ford
Impact in
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
- Metastasis and carcinoma case studies
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Gastric Cancer Management and Outcomes 10
- Lung Cancer Treatments and Mutations 7
- Oncology 17
- Colorectal Cancer Treatments and Studies 12
- Colorectal Cancer Surgical Treatments 3
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- David Cunningham (10 shared papers)Ian Chau (6 shared papers)Andrea Marshall (5 shared papers)Janet Dunn (5 shared papers)Natalie Cook (3 shared papers)Tobias Janowitz (2 shared papers)Gary Middleton (4 shared papers)Jane Blazeby (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (4 papers)British Journal of Cancer (3 papers)European Journal of Cancer (2 papers)PharmacoEconomics (1 paper)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Hugo Ford
29 papers receiving 1.1k citations
Hugo Ford's Hit Papers
Peers
Comparison fields: 5 of 65
- Pulmonary and Respiratory Medicine 614
- Gastroenterology 102
- Oncology 507
- Internal Medicine 27
- Surgery 213
Countries citing papers authored by Hugo Ford
This map shows the geographic impact of Hugo Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Ford more than expected).
Fields of papers citing papers by Hugo Ford
This network shows the impact of papers produced by Hugo Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Ford. The network helps show where Hugo Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside Hugo Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial Hit paper breakdown → | 2013 | 413 |
| 2 | 2008 | 176 | |
| 3 | 2004 | 112 | |
| 4 | Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed. | 2003 | 56 |
| 5 | 2016 | 41 | |
| 6 | 2011 | 35 | |
| 7 | 2004 | 33 | |
| 8 | Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331. | 2002 | 32 |
| 9 | 2004 | 29 | |
| 10 | 1999 | 22 | |
| 11 | 1994 | 21 | |
| 12 | 2000 | 21 | |
| 13 | 2013 | 20 | |
| 14 | 2014 | 19 | |
| 15 | 2007 | 19 | |
| 16 | 2015 | 17 | |
| 17 | 2024 | 15 | |
| 18 | 2006 | 11 | |
| 19 | 2014 | 10 | |
| 20 | 2013 | 9 |
About Hugo Ford
Hugo Ford is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (10 papers), Lung Cancer Treatments and Mutations (7 papers), Esophageal Cancer Research and Treatment (6 papers), Colorectal Cancer Surgical Treatments (3 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal and Anal Carcinomas (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (614 citations), Gastroenterology (102 citations), Oncology (507 citations), Internal Medicine (27 citations) and Surgery (213 citations). Hugo Ford has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include David Cunningham, Ian Chau, Andrea Marshall, Janet Dunn, Natalie Cook, Tobias Janowitz, Gary Middleton, Jane Blazeby, Stephen Falk and Paula Kareclas. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, European Journal of Cancer and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.